Trial of Decitabine in Patients With Acute Myeloid Leukemia

NCT00260832 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

485

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Cytarabine or Supportive Care
DRUG: Dacogen (decitabine) only

Sponsor

Eisai Inc.